Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab

被引：0
|
作者：
Nash, Peter [1 ]
McInnes, Iain [2 ]
Ritchlin, Christopher T. [3 ]
Tam, Lai-Shan [4 ]
Soriano, Enrique [5 ,6 ]
Starr, Michael [7 ]
Rampakakis, Emmanouil [8 ]
Lavie, Frederic [9 ]
Shawi, May [10 ]
Baraliakos, Xenofon [11 ]
Mease, Philip J. [12 ,13 ]
机构：
[1] Griffith Univ, Sch Med, Brisbane, Qld, Australia
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Univ Rochester, Med Ctr, Dept Med Allergy Immunol & Rheumatol, Rochester, NY 14642 USA
[4] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[5] Hosp Italiano Buenos Aires, Internal Med Serv, Rheumatol Sect, Buenos Aires, DF, Argentina
[6] Univ Inst Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[7] McGill Univ, Hlth Ctr, Div Rheumatol, Montreal, PQ, Canada
[8] McGill Univ, Dept Pediat, JSS Med Res, Sci Affairs, Montreal, PQ, Canada
[9] Janssen Pharmaceut Co Johnson & Johnson, Paris, France
[10] Janssen Res & Dev LLC, Immunol, Titusville, NJ USA
[11] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Herne, Germany
[12] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[13] Univ Washington, Sch Med, Seattle, WA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
BIOLOGIC-NAIVE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1419
引用
收藏
页码：2785 / 2787
页数：3
相关论文
共 50 条
  • [1] IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB
    Nash, P.
    Mcinnes, I.
    Ritchlin, C. T.
    Tam, L. S.
    Soriano, E.
    Starr, M.
    Rampakakis, E.
    Lavie, F.
    Shawi, M.
    Baraliakos, X.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1771 - 1772
  • [2] Guselkumab Efficacy in Active Psoriatic Arthritis Patients with or Without Hyperuricemia: Post-hoc Analysis of Two Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
    Felten, Renaud
    Widawski, Laura
    Spielman, Lionel
    Gottenberg, Jacques-Eric
    Duret, Pierre-Marie
    Rampakakis, Emmanouil
    Sharaf, Mohamed
    Constantin, Caren
    Campana, Vincenza
    Messer, Laurent
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4429 - 4432
  • [3] Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study
    Coates, Laura C.
    Gossec, Laure
    Zimmermann, Miriam
    Shawi, May
    Rampakakis, Emmanouil
    Shiff, Natalie J.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Nash, Peter
    Mease, Philip J.
    Helliwell, Philip S.
    RMD OPEN, 2024, 10 (01):
  • [4] Efficacy of guselkumab in bionaive psoriatic arthritis patients with severe disease activity: post hoc analysis of Phase 3, randomized, double-blind, placebo-controlled study
    Ritchlin, Christopher T.
    Lubrano, Ennio
    Chimenti, Maria Sole
    Leibowitz, Evan
    Sharaf, Mohamed
    Rampakakis, Emmanouil
    Chakravarty, Soumya
    Nantel, Francois
    Lavie, Frederic
    Deodhar, Atul
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [5] INDIVIDUAL ENTHESEAL POINTS HAVE DIFFERENTIAL FREQUENCY OF INVOLVEMENT AND IMPACT ON PATIENT REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Coates, L.
    Mcinnes, I.
    Aydin, S.
    Kishimoto, M.
    Mease, P. J.
    Shawi, M.
    Zimmermann, M.
    Rampakakis, E.
    Lavie, F.
    Mcgonagle, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 220 - 221
  • [6] Individual Entheseal Points Have Differential Frequency of Involvement and Impact on Patient Reported Outcomes in Patients with Active Psoriatic Arthritis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies
    Coates, Laura
    McInnes, Iain
    Aydin, Sibel
    Kishimoto, Mitsumasa
    Mease, Philip J.
    Shawi, May
    Zimmermann, Miriam
    Rampakakis, Emmanouil
    Lavie, Frederic
    McGonagle, Dennis
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4398 - 4400
  • [7] Cardiovascular safety of eptinezumab: A pooled analysis of double-blind, randomized, placebo-controlled studies
    Smith, T. R.
    Spierings, E. L. H.
    Cady, R.
    Hirman, J.
    Ettrup, A.
    Shen, V
    HEADACHE, 2021, 61 : 112 - 112
  • [8] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136): : 2213 - 2224
  • [9] Efficacy of Guselkumab in Bionaive Psoriatic Arthritis Patients with Severe Disease Activity: Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Ritchlin, Christopher
    Lubrano, Ennio
    Chimenti, Maria Sole
    Leibowitz, Evan
    Sharaf, Mohamed
    Adelakun, Oyediran
    Rampakakis, Emmanouil
    Nantel, Francois
    Lavie, Frederic
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2999 - 3001
  • [10] GUSELKUMAB EFFICACY IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS BY BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Deodhar, Atul
    Mease, Philip J.
    Boencke, Wolf-Henning
    Tesser, John
    Schiopu, Elena
    Chakravarty, Soumya D.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Shawi, May
    Jiang, Yusang
    Sheng, Shihong
    Agarwal, Prasheen
    Merola, Joseph F.
    McInnes, Iain B.
    Ritchlin, Christopher T.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S108 - S109
12345